-
hcup-us.ahrq.gov/reports/statbriefs/sb23.jsp
December 23, 2007 - HCUP data include OB-GYN, ENT, orthopedic, cancer, pediatric, public, and academic medical hospitals. … with DRG=288 Other operations on stomach
Next, we excluded cases with stomach and intestinal cancers … with the following ICD-9-CM diagnosis codes:
– 1500 to 1599 Stomach and intestinal cancers
– 2301 … to 2309 In-situ cancers
Finally, we excluded cases without any of the following ICD-9-CM obesity
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
January 01, 2013 - electrolyte
disorders 14,325,172 0 0.00 1.00 0.22 0.42
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent
of Total
692: Radiotherapy 1,114 0.01%
693: Chemotherapy 62,706 0.44%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07%
690 … 18,144 0.13%
692: Radiotherapy 1,115 0.01%
693: Chemotherapy 58,907 0.44%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13%
692: Radiotherapy 1,207 0.01%
693: Chemotherapy 61,609 0.44%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14%
692: Radiotherapy 1,534 0.01%
693: Chemotherapy 61,552 0.44%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comformat_01.txt
December 08, 2004 - "19881",
"19882",
"19889",
"1990 ",
"1991 " = "METS" /* Metastatic cancer … V1084",
"V1085",
"V1086",
"V1087",
"V1088",
"V1089",
"V109 " = "TUMOR … " /* Solid tumor without metastasis */
"7010 ",
"7100 ",
"7101 ",
"7102 ", … 409,410,411,412,413,414,473,492 = "YES" ;
VALUE CANCDRG /* Cancer
-
hcup-us.ahrq.gov/reports/statbriefs/sb94.pdf
November 01, 2008 - , if known8
Length of stay less than two days
Any diagnosis code for immunocompromised state or cancer … Any cancer DRG
See AHRQ’s Patient Safety Indicators Technical Specifications document for further … HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals … in length among those aged 18 and
over or obstetric admissions, and excludes immunocompromised and cancer … in length among those aged 18 and
over or obstetric admissions, and excludes immunocompromised and cancer
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06%
690 … & neoplasms of uncertain behavior 6,509 0.08%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/datainnovations/raceethnicitytoolkit/or26.jsp
August 01, 2014 - Errors may be compounded when systems interact; for example, cancer & other disease registries often … the same top two causes of death through the two decades in this study (cardiovascular disease and cancer … , C V D; Whites: influenza and pneumonia, chronic lower respiratory disease, unintentional injury, cancer … , C V D; Whites: unintentional injury, Alzheimer's, chronic lower respiratory disease, cancer, C V D. … In order from highest rate to lowest, the causes are all causes, C V D, cancer, unintentional injury,
-
hcup-us.ahrq.gov/reports/natstats/commdx/table1d.htm
February 11, 2011 - Secondary malignancies [42] 20,731 11.99 0.06 … Cancer of bronchus, lung [19] 36,846 21.34 0.11 … Cancer of prostate [29] 22,572 14.48 0.06 … Cancer of bladder [32] 2,124 1.36 0.01
-
hcup-us.ahrq.gov/db/nation/nrd/stats/FileSpecifications_NRD_2013_Severity.TXT
January 01, 2013 - disorders
NRD 2013 Severity 21 CM_METS 2 Num AHRQ comorbidity measure: Metastatic cancer … Renal failure
NRD 2013 Severity 29 CM_TUMOR 2 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/db/nation/nrd/stats/FileSpecifications_NRD_2010_Severity_V2.TXT
January 01, 2010 - disorders
NRD 2010 Severity_V2 21 CM_METS 2 Num AHRQ comorbidity measure: Metastatic cancer … failure
NRD 2010 Severity_V2 29 CM_TUMOR 2 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/db/nation/nrd/stats/FileSpecifications_NRD_2015Q1Q3_Severity.TXT
October 31, 2017 - 2015Q1Q3_Severity 21 CM_METS 2 Num AHRQ comorbidity measure: Metastatic cancer … NRD_2015Q1Q3_Severity 29 CM_TUMOR 2 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/db/nation/nrd/stats/FileSpecifications_NRD_2014_Severity.TXT
January 01, 2014 - disorders
NRD 2014 Severity 21 CM_METS 2 Num AHRQ comorbidity measure: Metastatic cancer … Renal failure
NRD 2014 Severity 29 CM_TUMOR 2 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/db/nation/nrd/stats/FileSpecifications_NRD_2012_Severity_V2.TXT
January 01, 2012 - disorders
NRD 2012 Severity_V2 21 CM_METS 2 Num AHRQ comorbidity measure: Metastatic cancer … failure
NRD 2012 Severity_V2 29 CM_TUMOR 2 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/db/nation/nrd/stats/FileSpecifications_NRD_2011_Severity_V2.TXT
January 01, 2011 - disorders
NRD 2011 Severity_V2 21 CM_METS 2 Num AHRQ comorbidity measure: Metastatic cancer … failure
NRD 2011 Severity_V2 29 CM_TUMOR 2 Num AHRQ comorbidity measure: Solid tumor
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
November 08, 2017 - electrolyte
disorders 5,377,720 0 0.00 1.00 0.22 0.42
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06%
690 … & neoplasms of uncertain behavior 3,745 0.07%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
January 01, 2014 - Variable / Label
N
N
Miss Minimum Maximum Mean Std Dev
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 7,071,762 0 0.00 1.00 0.11 0.31
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06%
690 … Percent
of Total
692: Radiotherapy 586 0.01%
693: Chemotherapy 29,695 0.42%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
January 01, 2013 - Variable / Label
N
N
Miss Minimum Maximum Mean Std Dev
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 7,119,563 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06%
690 … Percent
of Total
692: Radiotherapy 664 0.01%
693: Chemotherapy 30,425 0.43%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
January 01, 2012 - electrolyte
disorders 3,195,782 0 0.00 1.00 0.08 0.27
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15%
110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG
APRDRG Frequency
Percent
of Total
693: Chemotherapy 32,305 1.01%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01%
710: Infectious & parasitic diseases including HIV w O.R